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Abstract
Background: Neuroinflammation evolves as a multi-facetted response to focal cerebral ischemia. It involves
activation of resident glia cell populations, recruitment of blood-derived leucocytes as well as humoral responses.
Among these processes, phagocyte accumulation has been suggested to be a surrogate marker of
neuroinflammation. We previously assessed phagocyte accumulation in human stroke by MRI. We hypothesize that
phagocyte accumulation in the macrosphere model may resemble the temporal and spatial patterns observed in
human stroke.
Methods: In a rat model of permanent focal ischemia by embolisation of TiO2-spheres we assessed key features of
post-ischemic neuroinflammation by the means of histology, immunocytochemistry of glial activation and influx of
hematogeneous cells, and quantitative PCR of TNF-a, IL-1, IL-18, and iNOS mRNA.
Results: In the boundary zone of the infarct, a transition of ramified microglia into ameboid phagocytic microglia
was accompanied by an up-regulation of MHC class II on the cells after 3 days. By day 7, a hypercellular infiltrate
consisting of activated microglia and phagocytic cells formed a thick rim around the ischemic infarct core.
Interestingly, in the ischemic core microglia could only be observed at day 7. TNF-a was induced rapidly within
hours, IL-1b and iNOS peaked within days, and IL-18 later at around 1 week after ischemia.
Conclusions: The macrosphere model closely resembles the characteristical dynamics of postischemic
inflammation previously observed in human stroke. We therefore suggest that the macrosphere model is highly
appropriate for studying the pathophysiology of stroke in a translational approach from rodent to human.
Background
Inflammation plays an important role in the cascade of
events following cerebral ischemia that may impact on
the extent of tissue damage, infarct demarcation, tissue
repair und functional recovery, and may hence act as a
key target for therapeutic intervention [1,2].
Animal research has characterized postischemic
inflammation as a multi-facetted response involving acti-
vation of resident glia cells and recruitment of blood-
derived leucocytes as well as cascades of humoral
responses [2-4]. In the classical transient middle cerebral
artery occlusion (tMCAO) model, hematogeneous cells
including polymorphonuclear neutrophils (PMN) and
macrophages rapidly infiltrate the ischemic region [5-7].
Translating rodent research into the situation of
human stroke, substantial progress has been made in
visualizing aspects of postischemic inflammation in man.
Starting with the first in vivo visualization of peripheral
benzodiazepine receptor-expressing inflammatory cells
using Positron Emission Tomography (PET) and the
radiotracer [11C]PK11195 [8], postischemic inflammation
has been repeatedly characterized by PET [8-11], mag-
netic resonance imaging (MRI) [12], and cell specific
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contrast agents detected by MRI [13-15]. Early histo-
pathological descriptions suggest a significant impact of
permanent versus transient ischemia on the dynamics of
inflammation [6]. Additionally, in the classical tMCAO
model, tissue damage and glia activation evolve in com-
plex spatial and temporal dynamics that make it difficult
to interpret the results and to translate them into the
human situation [16,17]. Different dynamics of MRI sig-
natures in the tMCAO model and human stroke further
complicate a translational approach [15]. Accordingly, we
searched for an experimental stroke model with particu-
lar regard to the dynamics of postischemic inflammation
that resembles the human situation.
In the rat macrosphere model, permanent focal ische-
mia is induced by intra-arterial embolization of a
defined number of TiO2 spheres into the middle cere-
bral artery (MCA). With respect to parameters such as
infarct development over time, final lesion size and clin-
ical outcome, this model is comparable to the estab-
lished pMCAO (permanent MCAO) model using an
intraluminal thread [18,19]. However, in contrast to the
permanent suture model, hypothalamic injury followed
by pathological hyperthermia is avoided in the macro-
sphere model [20,21]. Moreover, macrosphere injection
mimics arterio-arterial embolism of arteriosclerotic pla-
que material as the leading etiology of human stroke,
while the thread occlusion model rather simulates a
thromboembolic event with subsequent thrombolysis
and large-vessel reperfusion [22]. Importantly, neuroin-
flammation has not been described in an arterio-arterial
embolic stroke model to date.
Hence, we investigated key features and dynamics of
postischemic inflammation in the macrosphere model
and compared our findings to the human situation as
revealed by previous PET and MRI Studies.
Methods
Animals and Surgery
All animal procedures were in accordance with the Ger-
man Laws for Animal Protection and were approved by
the local animal care committee and local governmental
authorities. Male Wistar rats (n = 33) weighing 270-340
g were anesthetized with 5% isoflurane and maintained
with 2.5% isoflurane in 65%/35% nitrous oxide/oxygen.
Throughout the surgical procedure body temperature
was maintained at 37.0°C with a thermostatically con-
trolled heating pad. Ischemia was produced by intra-
arterial injection of 4 TiO2 spheres into MCA as
described elsewhere [19]. Briefly, after exposure of the
left common carotid artery (CCA), internal carotid
artery (ICA) and external carotid artery (ECA), the ECA
and the pterygopalatine branch of the ICA were ligated.
PE-50 tubing was filled with saline and four TiO2
macrospheres (Ø 0.315-0.355 mm; BRACE, Alzenau,
Germany). The macrospheres were advanced via ICA
into the MCA by a slow injection of approximately 0.2
ml saline (Figure 1A). In sham-operated animals, the
same operation procedure was used without injection of
macrospheres (n = 4). Following operation, the animals
were transferred to their cages after they had fully
recovered from anaesthesia. During the experiment all
animals received an intensified care with subcutaneous
saline injections (5 ml 0.9%NaCl/day) and moistening of
food pellets. Animals in apparent clinical distress were
sacrificed, excluded from the study and replaced.
Histology and Immunocytochemistry
Groups of n = 3 animals each were allowed to survive for
24 hours, 3 days, and 7 days after MCA embolisation with
TiO2 spheres before they were decapitated under deep
anaesthesia with isoflurane. The brains were rapidly
removed, frozen in 2-methylbutane, and stored at -80°C
prior to further histological and immunocytochemical pro-
cessing. Adjacent serial coronal brain sections were cut at
500 μm intervals (slice thickness 10 μm) and stained with
hematoxylin and eosin (H&E) according to standard pro-
tocols. Anti-NeuN (clone A60, dilution 1:1000, Millipore,
Billerica, USA, cat-# MAB377) was performed to recog-
nize the DNA-binding between neuron and the specific
protein NeuN, which is presented in most CNS/PNS neu-
ronal cell types. For the identification of astrocytes, we
used mAb against Glial Fibrillary Acidic Protein (GFAP)
(clone GFAP, dilution 1:1000, Millipore, Billerica, USA,
cat-# MAB360) and Vimentin (VIM) (dilution 1:2000,
Millipore, Billerica, USA, cat-# MAB3400). The mAb
against the complement receptor 3/CD11b identified
microglia/macrophages (clone OX42, dilution 1:1000,
AbD Serotec, Oxford, UK, cat-# MCA275R). Microglia
activation was assessed by staining for MHC class II
(clone Ox6, dilution 1:400, AbD Serotec, Oxford, UK, cat-
#MCA46G). Phagocytic cells were identified with mAb
ED1 (clone ED1, dilution 1:1000, AbD Serotec, Oxford,
UK, cat-# MCA341). A double staining with anti-Iba1
(dilution 1:1000, Wako, Neuss, Germany, cat-# 019-
19741) and anti-NeuN was performed additionally. Iba1 is
up-regulated upon activation of microglia allowing the dis-
crimination between resting and activated microglia. For
visualization, the ABC Elite kit (Vector Laboratories,
Burlingame, CA, USA) with diaminobenzidine (Sigma,
Munich, Germany) or Vector SG substrate kit for peroxi-
dase (Vector laboratories, Burlingame, CA, USA.) for anti-
NeuN staining as the final reaction product was used.
To quantify phagocytic cells at day 7, the area of ED1-
positive cells was measured by the analysis software
Image J (1.40G, National Institutes of Health, USA) and
related to the ipsilateral hemisphere.
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Figure 1 Characterization of the macrosphere stroke model. (A) Basal view of the rat brain displaying the cerebral arteries following
macrosphere-injection into the MCA. One macrosphere is located in the origin of the MCA and the distal ICA (arrow). Bar: 5000 μm.
(B) Schematic drawing of the rat brain (dorsal view) to localize tissue samples collected from the ischemic lesion [A] and contralateral cortex [B].
(C) Representative H&E staining of coronal brain sections demonstrating the extent of the ischemic lesion 7 days after ischemia induction.
Objective 1×; bar: 5000 μm.
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Quantitative real-time polymerase chain reaction (PCR)
For PCR analysis, another group of animals were sacri-
ficed 4 hours (n = 5), 24 hours (n = 5), 3 days (n = 5),
and 7 days (n = 5) after ischemia induction. In addition,
4 sham-operated animals without infarct served as con-
trols. For RNA isolation, a sample of the cortex within
the infarct core (sample A) and contralateral hemisphere
(sample B) were prepared along with non-ischemic cor-
tex from control brains (Figure 1B). Approximately 30
to 50 mg tissue per tissue sample (wet weight) were
obtained. Total RNA was prepared using the Trizol
reagent (Gibco BRL, Gaithersburg, MD) and quantified
spectrophotometrically. One microgramm RNA was
reversely transcribed using oligo (dT)19 (G/A/C) primers
and Superscript II reverse transcriptase (Gibco-BRL,
Gaithersburg, MD) according to manufacturer’s proto-
col. Quantitative assessment of TNF-a, IL-1b, IL-18 and
iNOS gene expression levels was performed using a
7900HT Fast Real-Time PCR System (Applied Biosys-
tems, Weiterstadt, Germany) and the Sybr Green
Universal Master Mix (Applied Biosystems) and gene-
specific primer pairs as described previously [23,24]. In
all PCR analyses, glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) [24] was used as the reference gene
since it exhibited constant expression levels under all
tested conditions. Relative gene expression levels were
determined according to the manufacturer’s ΔΔCt
method. For quantification of PCR data, mRNA levels of
the ipsilateral hemisphere were compared to levels of
the contralateral hemisphere as well as to values of con-
trol animals.
Statistical analysis
The statistical analysis was performed with SigmaPlot 11
(Systat Software Inc, California, USA). Data are pre-
sented as mean ± SD. For the analysis of PCR results,
two-way analysis of variance (ANOVA) with a post hoc
test of Holm-Sidak was used. Statistical significance was
set at the less than 5% level (p < 0.05).
Results
Characterization of the macrosphere model
Four TiO2 spheres were injected into the ICA after liga-
tion of the pterygopalatine artery, leading to a perma-
nent occlusion within the ICA/MCA vessel arborisation.
In all animals, one or more macrospheres directly
blocked the proximal MCA (Figure 1A). H&E staining
verified the infarct localization in the MCA territory of
all animals (Figure 1C).
All animals showed circling behavior 24 hours after
infarct induction but recovered incompletely till
72 hours. Animals in clinical distress were sacrificed,
excluded from the study and replaced (n = 4).
Infarct demarcation
One day after induction of stroke, the infarction is already
well demarcated from vital tissue (Figure 2A, D, G). H&E
staining showed eosinophilic coagulation necrosis in the
ischemic territory (Figure 2A) and loss of GFAP staining
indicated cell loss and edema within the infarct core
(Figure 2D). The infarct border is even more clear-cut 3
days after macrosphere injection (Figure 2B, E, H) and the
surrounding tissue appears to be slightly hypercellular.
Around day 7, a sharp infarct demarcation with a sur-
rounding hypercellular infiltrate containing reactive astro-
cytes (revealed by GFAP) and phagocytic cells containing
transformed microglia and hematogeneous macrophages
(identified by ED1) developed (Figure 2C, F, I). The
dynamics of infarct demarcation and astrogliosis did not
differ between subcortical and cortical regions at the
observation time-points, giving further evidence to the
notion that the infarcts developed promptly and in a syn-
chronous way in basal ganglia and cortical areas.
The mean ischemic lesion volume of all animals was
161 mm3 ± 90.
The contralateral hemisphere did not show any
changes in immunoreactivity at any time point (Figure 2).
Cellular inflammatory response
In the infarct core morphological signs of microglial
activation could be shown as early as 24 h after induc-
tion of focal ischemia by more intense Ox42-staining.













Figure 2 Infarct demarcation and cellular response. H&E (A-C),
GFAP (D-F) and ED1 (G-I) staining 24 h, 3 d, and 7 d after infarct
induction. The infarct is increasingly demarcated over time by
reactive astrocytes that accumulate in the vital tissue bordering the
infarct. Scars circumscribe the infarcted tissue but GFAP-positive
cells do not enter the infarct zone up to day 7. Phagocytic cells
including transformed microglia and hematogeneous macrophages
accumulate at the infarct border in the necrotic tissue. Objective:
1×; bar: 200 μm.
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Some amoeboid microglia with rounded cell bodies were
also present (Figure 3A, D, G). By day 3, microglia cells
started to form a hypercellular rim around the infarct
core, exhibiting signs of activation by ED1-staining as an
indication for phagocytosis. MHC class II-positive cells
with stellate morphology were more numerous and
extended further into vital tissue compared to ED1-posi-
tive cells. (Figure 3B, E, H). At day 7, a dense cellular
wall of microglial cells surrounded the ischemic lesion
(Figure 3C, F, I). In the core of the lesion, some - most
likely avital - cells exhibited a granular Ox42 immuno-
signal. There was abundant expression of ED1 and
MHC class II-positive cells constituting a rim around
the infarct border, with more scattered cells positive for
both markers at the infarct core. At day 7, the area of
ED1-positive cells (54 mm3 ± 26) extended over 9 to
20% of the affected hemisphere.
The contralateral hemisphere did not show changes in
immunoreactivity at any time point.
Cellular interactions in the infarct demarcation zone
7 days after MCAO, eosinophilic coagulation necrosis
(Figure 4A) and neuronal degeneration (Figure 4B)
could be observed in the infarct core. ED1+ phagocytes
(Figure 4C) and activated microglia (Figure 4D, brown)
accumulated at the infarct border and interacted with
neurons (Figure 4D, red arrows). Astrocytic activation
(protoplasmic astrocytes) was clearly visible at the bor-
der of the infarct, but not in the infarct core. A demar-
cation of a scar-like formation could be observed at the
periphery of the infarct core (Figure 4E, F) and vimentin
immunoreactivity depicted immature astrocytes indicat-
ing proliferation of astrocytes.
Cytokine response
The proinflammatory cytokines TNF-a, IL-1b, iNOS
and IL-18 were quantified in the infarct core and homo-
topic contralateral regions over time (Figure 1B). Perma-
nent MCAO induced the early upregulation of TNF-a
mRNA within the first 4 hours after ischemia. TNF-a
stayed upregulated at significant levels for the entire
time period studied (Figure 5A). IL-1b and iNOS were
upregulated at a slower rate and peaked 72 hours after
onset of ischemia (Figure 5B, C). IL-18 expression was
detectable at low levels within the first days and peaked
at 7 days after stroke (Figure 5D).
Discussion
In the macrosphere model, the intra-arterial injection of
4 TiO2 spheres leads to permanent occlusion of the














Figure 3 Cellular inflammatory response at the infarct border.
Phagocytic cells (ED1, A-C), microglia (Ox42, D-F) and activated
microglia (Ox6, G-I) are responding to focal cerebral ischemia. Over
the course of one week after induction of ischemia, those cells










Figure 4 Cellular interaction in the infarct demarcation zone.
Infarct demarcation zone at day 7 after infarct induction (left:
healthy tissue; right: infarct zone) with different stainings: H&E (A),
NeuN (B), ED1 (C), anti NeuN antibody and anti-Iba1 antibody (D),
GFAP (E) and VIM (F). The infarct zone was clearly demarcated (A-F)
Eosinophilic coagulation (A) and neuronal degeneration (B) occurred
at the infarct. ED1+ phagocytes (C) and activated microglia (D,
brown) are visible within the infarct. Interactions between neurons
and activated microglia occurred (D, red arrows). GFAP-positive
astrocytes (E) demarcate the lesion forming an astrocytic scar in the
vital tissue adjacent to the infarct border. Vimentin
immunoreactivity (F) depicts proliferating astrocytes within the scar
(black arrow) as well as other cell types within the infarct (green
arrow). Objective: 40×; bar: 50 μm.
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MCA resulting in an ischemic lesion of the MCA-terri-
tory [20]. The interindividual variability of infarct
volume caused by different occlusion sites of the macro-
spheres is similar to other embolic stroke models. This
technique mimics arterio-arterial embolism of “hard”
atherosclerotic plaque material, the most frequent cause
of stroke in humans [22,25]. Moreover, in contrast to
the well-established suture model of permanent ische-
mia, the macrosphere model avoids hypothalamic injury
and subsequently hyperthermia [18,20,21], while
hypothalamic infarction is extremely rare in patients.
Hyperthermia may be a confounding factor in therapeu-
tic studies and may influence CNS inflammatory
responses as well. In those regards, the macrosphere
model offers clear advantages compared to the com-
monly used transient and permanent suture models, and
has therefore been suggested to represent a clinically
relevant model to study the pathophysiology of stroke.
In a proof-of-principles study we previously visua-
lized macrophage infiltration in human stroke by a
superparamagnetic iron oxide contrast agent (USPIO)
[14]. At 3-4 days after stroke onset, we detected subtle
contrast enhancement in only a minority of patients.
However, 6-8 days after onset of ischemia, we con-
sistently found signs of macrophage infiltration in
subcortical as well as cortical areas. Macrophage infil-
tration heterogeneously affected subregions of the
infarct with significant inter-individual differences.
This is in accordance with the dynamics of cellular
responses after permanent focal ischemia in primates
reported earlier [26]. Going back from “bedside to
bench”, two essential features of cellular responses in
the macrosphere model are reminiscent of the human
situation: (i) the slowly evolving macrophage infiltra-
tion at the end of the first post-infarct week, and (ii)
the heterogeneous distribution of the macrophage infil-
trate throughout the infarct.
In rodent models of tMCAO, the temporal evolution
of tissue damage has also been shown to be heteroge-
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Figure 5 Cytokine response. Quantitative real-time polymerase chain reaction (PCR) analyses of TNF-a (A), IL-1b (B), iNOS (C) and IL-18 (D)
mRNA levels shows upregulation of all cytokines within specific time windows. A rapid strong induction of TNF-a peaking at 4 h was
accompanied by a lower response of IL-1b and iNOS with a maximum at 72 h. IL-18 was induced very late around day 7. At each time point
after onset of infarct, n = 5 animals were studied, whereas 4 animals served as control. Bars represent mean ± SD; **p < 0.01; *p < 0.05
(compared to control animals); ++p < 0.01; +p < 0.05 (infarcted hemisphere compared to contralateral hemisphere).
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to cortical axis, which renders inflammatory responses
complex and difficult to assess [16,17]. Reperfusion
accelerates inflammation, facilitating the rapid infiltra-
tion of hematogeneous cells, to an early and diffuse
accumulation of PMNs throughout the infarct [5-7,27].
In contrast, rodent models of permanent MCAO
show rapid signs of tissue damage evolving in the
infarct core and succumbing to necrosis, while more
peripheral areas display a greater variability in the
severity of ischemia. After pMCAO, peripheral areas
are usually associated with incomplete necrosis, while
subcortical regions show only mild ischemic neuronal
damage without loss of neurons [28]. In a rat model
of pMCAO, direct surgical occlusion of the MCA led
to an accumulation of PMN leukocytes with a maxi-
mum at 48-72 hours [16], which is just as late as the
PMN infiltration seen after human stroke [7]. In a
monkey model of pMCAO, PMNs within the reactive
zone could be observed in modest numbers at
18 hours, and increased to 72 hours, while seven-day
old lesion showed PMNs in the central infarcted zone
only [16]. By comparing permanent and transient
MCAO in spontaneously hypertensive rats, the infil-
tration of neutrophils was moderate in pMCAO.
Furthermore, the activity of the neutrophil marker
myeloperoxidase was 2 to 3-fold increased, depending
of the reperfusion time in tMCAO compared to
pMCAO within the first day [27]. Those previous stu-
dies suggest that pMCAO models reflect the dynamics
of human postischemic inflammation much better
than tMCAO models do.
In this study, the extent of ischemic damage obtained
by macrosphere embolization corresponded to previous
experiments and was comparable to other pMCAO
models [18-21]. In contrast, our pMCAO model was dif-
ferent from the previously described photochemically
induced focal ischemia model that produces only a pure
neocortical infarction [29,30]. While the infarcted area
underwent necrosis, the surrounding tissue displayed an
increasing astrocyte reactivity over time as revealed by
GFAP-staining, a phenomenon that was similar to
photothrombosis [30,31]. With respect to the cellular
inflammatory response, we observed a transition of
ramified into ameboid phagocytic microglia in the
boundary zone of the infarct, with consecutive infarct
demarcation as late as three days after the induction of
ischemia, corresponding to the situation after photo-
thrombosis [29] as well as to that after human stroke
[4]. Stoll et al. observed the accumulation of phagocytes
in the border zone of human infarcts after 5 days [4].
This combined microglia/macrophage response was
accompanied by an up-regulation of MHC class II mole-
cules. In the ischemic core, morphological signs of
microglia activation could be detected by day 7, but not
at day 1, similar to the photothrombosis model
[17,30,32,33]. In human PET studies using the periph-
eral benzodiazepine ligand [11C]PK11195 as a surrogate
marker for inflammation to investigate the temporo-
spatial profile of microglia-activation and macrophage-
invasion [34-36] and MRI studies using ultrasmall
supermagnetic iron oxide (USPIO) to study the invasion
of blood-borne macrophages into human brain [12,37],
microglia activation in human stroke have been detected
to start as late as 3 days after onset of ischemia and
reached its maximum within one week [12,34-37]. Inter-
estingly, in the macrosphere model activated microglia
and macrophages established a particularly dense cellu-
lar wall around the infarct core after 7 days, whereas
reactive astrocytes had formed a ring already by day 3,
similar to the situation observed in the photothrombosis
model [29,31]. The time-course of cytokine release in
the macrosphere model differed slightly from the situa-
tion in the photothrombosis model. While we found a
rapid induction of TNF-a similar to photothrombosis, a
much later upregulation of IL-1b and iNOS occurred
peaking at day 3. TNF-a and IL-1b are synthesized by
PMNs [38] and therefore PMN accumulation may con-
tribute to TNF-a and IL-1b production-besides resident
microglia as a principle source-peaking at 72 hours. The
induction of IL-18 occurred even later and increased up
to day 7. This late induction of IL-18 is in good accor-
dance with the situation previously observed in the
photothrombosis model, where the maximum upregula-
tion was found at day 14, a time point not included in
our present study [23].
By comparing macrosphere model, human stroke and
tMCAO, key features of post-ischemic neuroinflamma-
tion, e.g. microglia activation, macrophages infiltration
throughout the infarct and phagocytic accumulation,
showed a similar temporal appearance in the macro-
sphere model in rats and human stroke, whereas
tMCAO in rats leads to a rapid development of inflam-
mation (Table 1).
Conclusions
The macrosphere model as a model of focal cerebral
ischemia resembles closely the dynamics of human
postischemic inflammation, imitating particularly the
slow time course of human neuroinflammation. There-
fore we suggest that the macrosphere model mimics
the clinical situation of human stroke better than the
commonly used model of transient middle cerebral
artery occlusion. Accordingly the rodent macrosphere
model is regarded most relevant for studying the
pathophysiology of stroke and possesses high clinical
relevance.
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